Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.91% Nasdaq Up0.87%

Alexza Pharmaceuticals Inc. (ALXA)

-NasdaqGM

4.53 Down 0.06(1.31%) 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue 729   729   729   728  
Cost of Revenue -   -   -   -  
Gross Profit 729   729   729   728  
Operating Expenses
Research Development6,219  7,023  4,784  5,010  
Selling General and Administrative4,113  4,606  2,338  2,904  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,603) (10,900) (6,393) (7,186)
Income from Continuing Operations
Total Other Income/Expenses Net(10,887)907  (195)609  
Earnings Before Interest And Taxes(20,490)(9,993)(6,588)(6,577)
Interest Expense222  280  333  380  
Income Before Tax(20,712)(10,273)(6,921)(6,957)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(20,712)(10,273)(6,921)(6,957)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (20,712) (10,273) (6,921) (6,957)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (20,712) (10,273) (6,921) (6,957)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.